Cancer Research UK logo.
SearchDonate
  • Search

A trial of nivolumab for diffuse large B cell lymphoma (CA209139)

Overview

Cancer types:

Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a drug called nivolumab for people with diffuse large B cell lymphoma (DLBCL). It is for people whose lymphoma has come back or is no longer responding to treatment.

Recruitment start: 1 February 2014

Recruitment end: 10 July 2015

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Johnson

Supported by

Bristol-Myers Squibb

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 30 Jul 2015

CRUK internal database number: 10820

Help and support